Even after a more than tenfold rise in the past five years, it's valid to argue that this AI stock is cheap.

Nike stock has fallen 78% and is leaving the S&P 100. Jim Osman examines whether the index exit could mark capitulation and a ...

In an interview with Zee Business Managing Editor Anil Singhvi as part of the channel's 'Market Mentors' series, Singhania ...

Small-cap stocks have been so miserable for so long that even a healthy beating of their large-cap peers across 2026 hasn’t ...

Last week, the Philippine Stock Exchange (PSE) hosted a cocktail reception to celebrate the latest milestone achieved by International Container Terminal Services Inc (ICT). It became the first listed ...

Sewing is not a quick budgeting fix. But for one 30-year-old, it has become a useful long-term skill that supports ...

Warren Buffett Quote of the Day: The quote is particularly relevant when investors rush into an asset simply because they see ...

CDT Environmental Technology Investment Holdings Limited rallied as waste-treatment contract wins spurred optimism; stocks ...

Bubs Australia (ASX:BUB) has secured permanent FDA approval for three infant formula products, opening the US private label opportunity.

Pyxis Oncology Inc. surged after promising clinical trial news, and stocks have been trading up by 9.4 percent. What Traders ...